Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma

Affiliations

• ¹ Department of Haematology-Oncology, National University Hospital, Singapore, Singapore.
• ² KYAN Therapeutics, Singapore, Singapore.
• ³ Cancer Science Institute of Singapore, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
• ⁴ Department of Haematology-Oncology, National University Hospital, Singapore, Singapore. [email protected].
• ⁵ Department of Haematology-Oncology, National University Hospital, Singapore, Singapore. [email protected].
• ⁶ Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.
• ⁷ Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
• ⁸ Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
• ⁹ Department of Pathology, National University Hospital, Singapore, Singapore.
• ¹⁰ Department of Diagnostic Imaging, National University Hospital Singapore, Singapore, Singapore.
• ¹¹ Cancer Science Institute of Singapore, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. [email protected].
• ¹² Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. [email protected].
• ¹³ N.1 Institute for Health, National University of Singapore, Singapore, Singapore. [email protected].
• ¹⁴ Department of Haematology-Oncology, National University Hospital, Singapore, Singapore. [email protected].
• ¹⁵ Cancer Science Institute of Singapore, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. [email protected].